PGT-M (formerly PGD) is an early genetic diagnosis test for embryos produced during IVF, prior to their transfer to the uterus.
By analysing DNA from each embryo, normal embryos can be preferentially selected to be transferred and begin the journey towards conceiving a healthy child.
For clinics in the UK, a condition must be approved by the Human Fertilisation & Embryology Authority (HFEA) to perform PGT-M. Igenomix are able to support clinics in their applications for additions to this list. Note that this restriction does not apply to non-UK clinics working with Igenomix UK.
G. Kakourou et al., The clinical utility of PGD with HLA matching a collaborative multi-centre ESHRE study. Human Reproduction, Vol.33, No.3 pp. 520–530. Fertility and Sterility
M De Rycke, et al., ESHRE PGD Consortium data collection XIV–XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013, Human Reproduction, Volume 32, Issue 10, October 2017, Pages 1974–1994.
